CA2014889A1 - Intra-rectal pharmaceutical foam compositions - Google Patents

Intra-rectal pharmaceutical foam compositions

Info

Publication number
CA2014889A1
CA2014889A1 CA2014889A CA2014889A CA2014889A1 CA 2014889 A1 CA2014889 A1 CA 2014889A1 CA 2014889 A CA2014889 A CA 2014889A CA 2014889 A CA2014889 A CA 2014889A CA 2014889 A1 CA2014889 A1 CA 2014889A1
Authority
CA
Canada
Prior art keywords
intra
foam compositions
pharmaceutical foam
rectal pharmaceutical
foam
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2014889A
Other languages
French (fr)
Other versions
CA2014889C (en
Inventor
John Norman Charles Healey
Marshall Whiteman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Chilcott Pharmaceuticals SARL
Original Assignee
Smith Kline and French Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10655759&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CA2014889(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Smith Kline and French Laboratories Ltd filed Critical Smith Kline and French Laboratories Ltd
Publication of CA2014889A1 publication Critical patent/CA2014889A1/en
Application granted granted Critical
Publication of CA2014889C publication Critical patent/CA2014889C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/122—Foams; Dry foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system

Abstract

Pharmaceutical compositions suitable for intra-rectal administration in the form of a foam are described which comprise a therapeutically effective amount of 5-aminosalicylic acid; a pharmaceutically acceptable aqueous carrier therefor, and means for generating a foam.
Methods for their preparation and their use in the treatment of ulcerative colitis are also described.
CA002014889A 1989-04-26 1990-04-19 Intra-rectal pharmaceutical foam compositions Expired - Lifetime CA2014889C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB898909559A GB8909559D0 (en) 1989-04-26 1989-04-26 Pharmaceutical compositions
GB8909559.0 1989-04-26

Publications (2)

Publication Number Publication Date
CA2014889A1 true CA2014889A1 (en) 1990-10-26
CA2014889C CA2014889C (en) 2000-05-30

Family

ID=10655759

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002014889A Expired - Lifetime CA2014889C (en) 1989-04-26 1990-04-19 Intra-rectal pharmaceutical foam compositions

Country Status (17)

Country Link
US (1) US5082651A (en)
EP (1) EP0395329B2 (en)
JP (1) JP2566662B2 (en)
KR (1) KR0179344B1 (en)
AT (1) ATE124261T1 (en)
AU (1) AU623245B2 (en)
CA (1) CA2014889C (en)
DE (1) DE69020422T3 (en)
DK (1) DK0395329T4 (en)
ES (1) ES2074124T5 (en)
GB (1) GB8909559D0 (en)
GR (2) GR3017367T3 (en)
HK (1) HK1004521A1 (en)
IE (1) IE67621B1 (en)
NZ (1) NZ233415A (en)
PT (1) PT93884B (en)
ZA (1) ZA903127B (en)

Families Citing this family (74)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9000485D0 (en) * 1990-02-09 1990-02-09 Pharmacia Ab FOAMABLE COMPOSITION FOR PHARMACEUTICAL USE, USE THEREOF AND METHOD OF TREATMENT
IT1243379B (en) * 1990-07-27 1994-06-10 Giuliani Spa PHARMACEUTICAL COMPOSITION SUITABLE FOR RECTAL ADMINISTRATION OF ACTIVE PRINCIPLES WHICH EXPLICATE A MEDICATION ACTION AT THE LEVEL OF THE COLON, PREVALENTLY TOPICAL
DE69133348T3 (en) * 1990-10-22 2011-05-12 Centre for Digestive Diseases Pty, Ltd. TREATMENT OF NON-INFLAMMABLE ENDURANCE
IT1247529B (en) * 1991-04-24 1994-12-17 Poli Ind Chimica Spa PHARMACEUTICAL COMPOSITIONS IN FOAM FORM FOR INTRAVAGINAL, SKIN AND ORAL ADMINISTRATION
EP0517274A1 (en) * 1991-06-07 1992-12-09 Byk Nederland BV Pharmaceutical enema
FR2713486B1 (en) * 1993-12-14 1996-02-09 Scophysa New compositions for foams, in particular rectal foams, and foams thus obtained.
DE4420735C2 (en) * 1994-06-15 1996-09-05 Allphamed Arzneimittel Gmbh Process for the production of mechanically stable, high-speed effervescent tablets
GB9414699D0 (en) * 1994-07-21 1994-09-07 Slagel David Aqueous foamable composition
GB9503119D0 (en) * 1995-02-17 1995-04-05 Durand Ltd Medication and apparatus and method of applying medication
US6166024A (en) 1995-03-30 2000-12-26 Mayo Foundation For Medical Education And Research Use of topical azathioprine and thioguanine to treat colorectal adenomas
US6326364B1 (en) 1999-02-08 2001-12-04 Cedars-Sinai Medical Center Use of 5-aminosalicylates as antimicrobial agents
JP2001072576A (en) * 1999-09-03 2001-03-21 Kissei Pharmaceut Co Ltd Oral medicinal composition
RU2266102C2 (en) * 1999-09-06 2005-12-20 Сетсуко УЕДА Composition for chemical piling
US8512718B2 (en) 2000-07-03 2013-08-20 Foamix Ltd. Pharmaceutical composition for topical application
DE60115465T2 (en) 2000-08-29 2006-08-03 Nobex Corp. IMMUNO-REGULATING COMPOUNDS, DERIVATIVES AND THEIR USE
CA2359812C (en) 2000-11-20 2004-02-10 The Procter & Gamble Company Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures
US8048924B2 (en) * 2001-08-29 2011-11-01 Biocon Limited Methods and compositions employing 4-aminophenylacetic acid compounds
EP1312368A1 (en) * 2001-11-19 2003-05-21 Dr. Falk Pharma Gmbh Composition comprising mesalazine for the treatment of inflammatory bowel diseases
WO2004037225A2 (en) * 2002-10-25 2004-05-06 Foamix Ltd. Cosmetic and pharmaceutical foam
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US20050186142A1 (en) * 2002-10-25 2005-08-25 Foamix Ltd. Kit and composition of imidazole with enhanced bioavailability
US9211259B2 (en) * 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
US20050069566A1 (en) * 2003-08-04 2005-03-31 Foamix Ltd. Foam carrier containing amphiphilic copolymeric gelling agent
US9668972B2 (en) * 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US8486376B2 (en) * 2002-10-25 2013-07-16 Foamix Ltd. Moisturizing foam containing lanolin
US20060193789A1 (en) * 2002-10-25 2006-08-31 Foamix Ltd. Film forming foamable composition
US8119150B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Non-flammable insecticide composition and uses thereof
US20050271596A1 (en) * 2002-10-25 2005-12-08 Foamix Ltd. Vasoactive kit and composition and uses thereof
US20080206161A1 (en) * 2002-10-25 2008-08-28 Dov Tamarkin Quiescent foamable compositions, steroids, kits and uses thereof
US7820145B2 (en) 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US20050205086A1 (en) * 2002-10-25 2005-09-22 Foamix Ltd. Retinoid immunomodulating kit and composition and uses thereof
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
US8119109B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Foamable compositions, kits and methods for hyperhidrosis
US20070292359A1 (en) * 2002-10-25 2007-12-20 Foamix Ltd. Polypropylene glycol foamable vehicle and pharmaceutical compositions thereof
US20060233721A1 (en) * 2002-10-25 2006-10-19 Foamix Ltd. Foam containing unique oil globules
US7704518B2 (en) * 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US20080317679A1 (en) * 2002-10-25 2008-12-25 Foamix Ltd. Foamable compositions and kits comprising one or more of a channel agent, a cholinergic agent, a nitric oxide donor, and related agents and their uses
US20070292355A1 (en) * 2002-10-25 2007-12-20 Foamix Ltd. Anti-infection augmentation foamable compositions and kit and uses thereof
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US10117812B2 (en) * 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
US7575739B2 (en) 2003-04-28 2009-08-18 Foamix Ltd. Foamable iodine composition
US8486374B2 (en) * 2003-08-04 2013-07-16 Foamix Ltd. Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
CA2536482C (en) * 2003-08-25 2012-07-24 Foamix Ltd. Penetrating pharmaceutical foam
US20100112088A1 (en) * 2003-08-29 2010-05-06 Jay Pravda Materials and methods for treatment of disorders associated with oxidative stress
US8916546B2 (en) 2003-08-29 2014-12-23 Therapeutic Research Llc Materials and methods for treatment and diagnosis of disorders associated with oxidative stress
US20050186147A1 (en) * 2004-02-04 2005-08-25 Foamix Ltd. Cosmetic and pharmaceutical foam with solid matter
DK1773767T3 (en) * 2004-07-07 2016-03-21 Biocon Ltd Synthesis of azo bound in immune regulatory relations
US20080152596A1 (en) * 2005-07-19 2008-06-26 Foamix Ltd. Polypropylene glycol foamable vehicle and pharmaceutical compositions thereof
KR20090064440A (en) * 2006-09-08 2009-06-18 포믹스 리미티드 Colored or colorable foamable composition and foam
US20080260655A1 (en) * 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
AU2007356328A1 (en) * 2006-11-14 2009-01-15 Tal Berman Stable non-alcoholic foamable pharmaceutical emulsion compositions with an unctuous emollient and their uses
US7645801B2 (en) 2007-01-29 2010-01-12 Alaven Pharmaceutical Llc Reduced irritant enema for treatment of inflammatory bowel disease (IBD)
KR20100038098A (en) * 2007-06-13 2010-04-12 제이 프라우다 Materials and methods for treatment and diagnosis of disorders associated with oxidative stress
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
US20090130029A1 (en) * 2007-11-21 2009-05-21 Foamix Ltd. Glycerol ethers vehicle and pharmaceutical compositions thereof
WO2009069006A2 (en) 2007-11-30 2009-06-04 Foamix Ltd. Foam containing benzoyl peroxide
WO2009072007A2 (en) 2007-12-07 2009-06-11 Foamix Ltd. Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
WO2010041141A2 (en) 2008-10-07 2010-04-15 Foamix Ltd. Oil-based foamable carriers and formulations
EP2242476A2 (en) * 2008-01-14 2010-10-27 Foamix Ltd. Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
WO2010125470A2 (en) 2009-04-28 2010-11-04 Foamix Ltd. Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
CA2769677A1 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
CA2769625C (en) 2009-07-29 2017-04-11 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
WO2011039638A2 (en) 2009-10-02 2011-04-07 Foamix Ltd. Topical tetracycline compositions
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
NZ600358A (en) 2009-11-23 2014-05-30 Cipla Ltd Topical foam composition
MX2012005883A (en) 2009-11-23 2012-10-09 Cipla Ltd Topical foam composition.
US8174881B2 (en) 2009-11-24 2012-05-08 Micron Technology, Inc. Techniques for reducing disturbance in a semiconductor device
US8809308B2 (en) 2012-11-09 2014-08-19 Scidose, Llc Enema composition for treatment of ulcerative colitis having long term stability
JP2015168654A (en) * 2014-03-07 2015-09-28 三笠製薬株式会社 Aqueous composition for nsaids containing foaming formulation
MX2020012139A (en) 2016-09-08 2021-01-29 Vyne Pharmaceuticals Inc Compositions and methods for treating rosacea and acne.
AU2017377017A1 (en) * 2016-12-16 2019-07-04 Ferring B.V. Rectal foam formulations

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1304682A (en) * 1969-02-03 1973-01-24
US3866800A (en) * 1969-02-12 1975-02-18 Alberto Culver Co Non-pressurized package containing self-heating products
AU1314370A (en) * 1970-02-09 1971-09-30 Alberto-Culver Company Gas-releasable and foamable compositions
US3997467A (en) * 1971-11-26 1976-12-14 Pharmacia Aktiebolag Foam forming composition
AR205589A1 (en) * 1974-10-09 1976-05-14 Reckitt & Colmann Prod Ltd INTRODUCING DEVICE OF AN AQUEOUS COMPOSITION INTO A BODY CAVITY
US4112942A (en) * 1974-10-09 1978-09-12 Reckitt & Colman Products Limited Method of preparing and administering a foam enema
DE2755224A1 (en) * 1976-12-15 1978-07-13 Procter & Gamble PAIN AND INFLAMMATION SOUNDING AGENT FOR LOCAL USE
US4211777A (en) * 1977-11-25 1980-07-08 Fisons Limited Compositions comprising a compound having sodium cromoglycate activity and aminosalicylic acid
WO1981002672A1 (en) * 1980-03-20 1981-10-01 Ferring Farma Lab Pharmaceutical composition and method for the treatment of colitis ulcerosa and crohn's disease
US4440763A (en) * 1981-03-18 1984-04-03 Block Drug Company, Inc. Use of 4-aminosalicyclic acid as an anti-inflammatory agent
SU1172558A1 (en) * 1983-07-11 1985-08-15 Научно-исследовательский институт проктологии Method of treatment of inflammatory diseases of large intestine
US4664256A (en) * 1983-09-06 1987-05-12 Farmaceutisk Laboratorium Ferring A/S Packaged stable enema solution or suspension containing 5-aminosalicyclic acid
US4657900A (en) * 1983-09-27 1987-04-14 Rowell Laboratories Pharmaceutical article of manufacture comprising a bisulfite stabilized aqueous solution of 5-aminosalicylic acid and method
FR2561919B1 (en) * 1984-04-03 1986-12-19 Roussel Uclaf PHARMACEUTICAL COMPOSITION CONSTITUTED ON THE ONE HAND, AS ACTIVE INGREDIENT, BY 9A, 11B-DICHLORO 16A-METHYL 21-OXYCARBONYLDICYCLOHEXYL METHYLOXY PREGNA-1,4-DIENE 3,20-DIONE AND ON THE OTHER HAND, BY A PHARM EXCIPIENT INERTE CAPABLE OF ALLOWING THE ACTION OF THE PRODUCT IN THE RECTUM OR THE COLON
US4889709A (en) * 1985-03-18 1989-12-26 Product Resources International, Inc. Aerosol foam with adsorbate and container containing same
US4752465A (en) * 1985-09-20 1988-06-21 Product Resources International, Inc. Aerosol foam
US4639367A (en) * 1985-03-18 1987-01-27 Product Resources International, Inc. Aerosol foam
EP0251462A3 (en) * 1986-05-28 1988-10-26 Lloyd I. Osipow Polymer-propellant compositions forming foamed structures
NZ224087A (en) * 1987-04-01 1990-08-28 Dak Lab As Topical pharmaceutical compositions containing 4- or 5- amino salicylic acid or a functional derivative thereof
US4945084A (en) * 1987-07-08 1990-07-31 Norman Oksman Method and composition for topically treating anorectal or other dermal wounds

Also Published As

Publication number Publication date
DK0395329T4 (en) 2000-04-10
GR3032575T3 (en) 2000-05-31
DE69020422T2 (en) 1995-11-16
DE69020422T3 (en) 2000-03-30
EP0395329A3 (en) 1991-11-21
JP2566662B2 (en) 1996-12-25
CA2014889C (en) 2000-05-30
DE69020422D1 (en) 1995-08-03
US5082651A (en) 1992-01-21
EP0395329B2 (en) 1999-11-17
EP0395329A2 (en) 1990-10-31
ATE124261T1 (en) 1995-07-15
JPH02295928A (en) 1990-12-06
PT93884B (en) 1996-10-31
DK0395329T3 (en) 1995-10-30
AU623245B2 (en) 1992-05-07
ZA903127B (en) 1991-12-24
KR0179344B1 (en) 1999-03-20
GR3017367T3 (en) 1995-12-31
IE901469L (en) 1990-10-26
KR900015741A (en) 1990-11-10
ES2074124T3 (en) 1995-09-01
AU5367290A (en) 1990-11-01
IE67621B1 (en) 1996-04-17
PT93884A (en) 1990-11-20
ES2074124T5 (en) 2000-01-16
GB8909559D0 (en) 1989-06-14
NZ233415A (en) 1991-05-28
EP0395329B1 (en) 1995-06-28
HK1004521A1 (en) 1998-11-27

Similar Documents

Publication Publication Date Title
CA2014889A1 (en) Intra-rectal pharmaceutical foam compositions
HUT55220A (en) Process for producing pharmaceutical composition suitable for systemic administration through the skin and comprising deprenyl as active ingredient
GR3018009T3 (en) Use of gamma-hydroxybutyric acid salts for preparing pharmaceutical compositions for use in the treatment of alcoholism, and the compositions obtained.
CA2125662A1 (en) Transdermally administered system containing acetylsalicylic acid for thrombosis therapy and cancer prophylaxis
PL325825A1 (en) Microemulsion for use as a carrier for administering active compounds
EP0348808A3 (en) Pharmaceutical formulations and process for preparing them
CA2004598A1 (en) Medicinal aerosol formulations
EG19642A (en) A process for the preparation of oral composition for the treatment of inflammatory bowel diseases
MY101593A (en) Sustained release preparation.
LU90297I2 (en) Rivastigmine its pharmaceutically acceptable salts and derivatives, in particular rivastigmine in the form of hydrogen tartrate
HUT48269A (en) Process for producing pharmaceutically active nukleozide and pharmaceutical compositions containing them
HUT50334A (en) Process for producing arylpiperazinyl-alkilenephenyl-p-heterocycluc compounds, pharmaceutically acceptable acid addition salts thereof and pharmaceutical compositions comprising the compounds as active ingredient
AU1950388A (en) Pharmaceutical formulation ensuring the transdermal absorption of the active ingredient and process for preparing same
AU6788687A (en) A pharmaceutical which can be administered nasally, a process for its preparation, and its use
HUT48623A (en) Herbicides comprising 2,5-dihydropyrrole derivatives as active ingredient and process for producing 2,5-dihydropyrrole derivatives
EP0362847A3 (en) The use of etoperidone for preparing a pharmaceutical composition for treating male impotence
HUT54166A (en) Process for producing 1,1-dioxocefem-4-carbothiol acid derivatives and pharmaceutical compositions comprising same as active ingredient
HU9201358D0 (en) 2-amino-pirimidine-4-carboxamide derivatives, process for their production and for the production of medical preparations containing them as active agents
CA2182812A1 (en) Pharmaceutical composition for systemic transdermal administration containing the active agent morphine-6-glucuronide
HUT49054A (en) Process for producing pharmaceutical compositions absorbed through the derm and comprising pyrazolo(1,5-a) pyridine derivatives as active ingredient
CA2101548A1 (en) Acylamino-alkylidenhydroxy-bisphosphonic acids useful in the therapy of osteoarticular diseases
GB2185478B (en) Novel e-valerolactam, pharmacologically active compositions thereof, processes for the preparation thereof and their medical use
EP0207514A3 (en) 1,4-dihydropyridine derivatives, process for preparing them, pharmaceutical composition and use
IT1255380B (en) Nitrobenzoyl alanines, process for their preparation, their use as therapeutic agents and pharmaceutical compositions containing them
HU904983D0 (en) Process for producing imidazo(5,1-b)quinazoline-9-one derivatives and their pharmaceutically acceptible salts as well as process for producing pharmaceutical preparatives containing these active substances

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry